NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘TPG Biotech’

18 July 2014

Roka Bioscience raised $60m via Nasdaq IPO

biotech Venture capital-backed molecular diagnostics specialist Roka Bioscience has raised $60m via an IPO on the Nasdaq exchange.

11 July 2014

TPG Capital life sciences arm launches first fund since 2008p

biomed_lrg The life sciences venture investment arm of TPG Capital has launched its fourth fundraise six years after hitting the market for its last vehicle.

4 June 2014

TPG Biotech leads $25m Series B for Trevi Therapeutics

medical monitor Biotech startup Trevi Therapeutics has raised a $25m Series B round led by TPG's life sciences vemnture investment arm TPG Biotech.

30 April 2014

Anti-ear disorder company Otonomy attracts more venture capital in $49m Series D

ear_lrg Venture-backed ear disorder treatment business Otonomy has picked up another $49m of funding through an oversubscribed Series D round.

17 April 2014

Venture capital-backed Epirus raises $36m, merges with Nasdaq-listed Zalicus

biotech_lrg Boston-based startup Epirus Biopharmaceuticals has secured $36m in a Series B round led by Livzon Mabpharm and agreed to merge with Nasdaq-listed group Zalicus.

22 October 2013

Aerie’s venture backers eye strong stake valuations from imminent IPOp

The venture capital-backers of eye disease treatment company Aerie Pharmaceuticals all plan to drop their stakes to below 20 per cent through the company’s impending IPO.

25 September 2013

Singapore’s EDBI backs mobile health technology company PatientSafe Solutions

The Singapore Economic Development Board’s investment arm EDBI has invested in mobile health technology business PatientSafe Solutions, taking its total Series C funding to $27m.

28 August 2012

Life sciences company CardioDx adds $58m led by Singapore’s Temasek

Life sciences company CardioDx has completed a $58m two-tranche equity financing from investors including Singapore sovereign wealth investor Temasek.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014